Y, Q., Z, W., H, Z., M, K., R, D., & J, Z. (2017). Oligosaccharide nanomedicine of alginate sodium improves therapeutic results of posterior lumbar interbody fusion with cages for degenerative lumbar disease in osteoporosis patients by downregulating serum miR-155. Dove Medical Press.
Style de citation Chicago (17e éd.)Y, Qu, Wang Z, Zhou H, Kang M, Dong R, et Zhao J. Oligosaccharide Nanomedicine of Alginate Sodium Improves Therapeutic Results of Posterior Lumbar Interbody Fusion with Cages for Degenerative Lumbar Disease in Osteoporosis Patients by Downregulating Serum MiR-155. Dove Medical Press, 2017.
Style de citation MLA (8e éd.)Y, Qu, et al. Oligosaccharide Nanomedicine of Alginate Sodium Improves Therapeutic Results of Posterior Lumbar Interbody Fusion with Cages for Degenerative Lumbar Disease in Osteoporosis Patients by Downregulating Serum MiR-155. Dove Medical Press, 2017.